· 34 min
We Will Be Living to 150: Peter Diamandis Maps the Future of Aging
We Will Be Living to 150: Peter Diamandis Maps the Future of Aging #aging #biotech #airevolution
Explore conversation3 July 2025 · 76 min
With Mattias Bernow · Hosted by Julian Issa
As CEO of Cellcolabs, Mattias Bernow breaks down the science, safety, and real promise of mesenchymal stem cells (MSCs). From anti-aging and inflammation to autoimmune issues and recovery, MSCs are emerging as one of the most powerful tools in modern medicine.
JUMP INTO THE CONVERSATION
As CEO of Cellcolabs, Mattias Bernow breaks down the science, safety, and real promise of mesenchymal stem cells (MSCs). From anti-aging and inflammation to autoimmune issues and recovery, MSCs are emerging as one of the most powerful tools in modern medicine.
In this eye-opening conversation, Mattias explains how stem cells actually work, what separates hype from science, and why quality (like GMP certification) is critical. We explore how stem cells could shift the future of healthcare—from invasive surgeries to simple infusions—and what’s still holding them back.
Whether you're longevity-curious or health-obsessed, this episode lays out the truth—and the timeline—of when stem cells could go mainstream.
· 34 min
We Will Be Living to 150: Peter Diamandis Maps the Future of Aging #aging #biotech #airevolution
Explore conversation· 81 min
What happens when intelligence stops being uniquely human?
Explore conversation· 64 min
What if rewriting our genetic code was no longer science fiction but a real tool to cure disease, slow aging, and even reimagine what it means to be human?
Explore conversation